Driving Pharmacovigilance forward with AI-enabled Data Intelligence

Streamline your drug safety routines with us

User interface preview

Our customers

Pharmacovigilance evolving rapidly.
We understand your pressures

What has changed in the last 3-5 years and how this affected
the industry
AI-Competition

Growth has slowed down as new aggressive?entrants with AI-tech shake the status quo.

Tech / digital age

New heavy investments have longer paybacks while the change cycles have shrinked.

Audits / regulatory pressure

The number of audits has increased. More and more non-compliance cases and mitigations.

People costs are rising

Good people leaving increases the retention costs, while the new talent costs more. Heavy investments in staff training and onboarding new talents.

New pinches strike harder
and harder

People are stressed and it is hard to predict their buying behaviors. Adverse reactions become more frequent.

Entering new markets

Entering new markets has become longer, less predictable, and more costly.

Global pressures dictate new requirements to drug safety processes

About DrugCard platform in numbers

100+
Languages

Supported by DrugCard

104+
Countries

Medical journals coverage

1817+
Local journals

Countiniously monitored

60%
Time savings

Compared to human-only approach

Our Management Team

Artem Horilyk

Chief Product Officer

Dmytro Horilyk

Chief Executive Officer

Myroslav Demchun

Chief Technology Officer

DrugCard solution designed for

CROs can manage more PV projects and improve screening results

When pharma outsource PV processes to CROs, they expect the highest quality and maximum search results to ensure full compliance with regulatory requirements. CROs can no longer guarantee the best results if they continue to read journals from cover to cover manually. Progressive CROs continuously discover innovative methods and tools to make their pharma customers fully compliant and satisfied. ? ? ??

Testimonials

Trusted customers that can provide everything you need to generate awareness, drive traffic, connect
DOVIL? MARCINK?
DOVIL? MARCINK?
Head of Global Drug Safety Unit and QPPV
Read More
DrugCards stands out as a mandatory operation tool, enabling our presence and activities with efficiency, cost saving and compliance with GVP regulations and other applicable requirements.
John Doe
John Doe@username
Read More
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
John Doe
John Doe@username
Read More
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Previous
Next

Frequently Asked Questions

Based on our customer feedback 50-70% time-savings could be achieved. However, we strongly welcome that planned time and cost savings were calculated for each project individually. Suppose it takes 30 minutes to read and another 5 more minutes to properly record evidence of reading, with DrugCard it would take only 3 minutes max, which is almost 10 times less.

Yes, we often face requests from our customers to help them screen printed hard copies of journals with scan quality being far from perfect. We use our own propitiatory OCR technology which delivers up to 99% accuracy of average quality scanned texts.

Yes, screening medical literature in local languages is DrugCards main competitive strength.? To date we successfully read 100+ languages and already covered 1500+ local journals. It means you can add search keywords in Greek, Hindi, Arabic, Japanese hieroglyphics, you name it.

Yes. Once DrugCard identifies a new drug mentioning in any local journal you will get an instant notification by email. On top you will receive weekly summary reports to make your life easier during audits and regulatory inspections.

On average, it takes up to 2-3 weeks. Of course, it depends on a particular country and the number of journals to be added. We once managed to add 100 custom journals for one of our clients in just a matter of 1 month.? But again, on average, you should consider time to add a new pack of journals in just 2-3 weeks.

It took us one year and a team of 5 people to develop the core. And 2 more years and 6 more people to make the platform friendly, reliable, bug-free, responsive and regulatory compliant. Hypothetically you could follow the same journey, but developing such a platform just for 1 company would be very costly and counterproductive.

We have seen cases where a significant part of the daily routine of PV specialists was freed and redirected to more intelligent work like signal detection, risk assessment, ICSR & case follow-up activities, quality control, etc. It is our strong belief that such rare expertise as pharmacovigilance should never be used for something that could be automated.

We see our main competition to be manual literature screening processes and a lack of willingness to change.? Even though some companies say they are happy with reading journals from cover to cover, our undisputed strengths would be (1) three to five times more hits discovered, (2) 50-70% time saved on screening (3) 99% accuracy of keywords recognition of average scanned texts. And since every project is different, we invite you to have a discussion and design your specific use case.

Enhance Your Pharmacovigilance

Unleash the power of AI, automation and traceability with DrugCard
Request a demo
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for submitting the form.

A dedicated company representative will contact you soon!

主站蜘蛛池模板: 婷婷人人爽人人爽人人片| 欧美激情视频二区| 天堂中文在线资源| 亚洲深深色噜噜狠狠爱网站| 911香蕉视频| 曰批全过程免费视频网址| 国产六月婷婷爱在线观看| 中文字幕欧美在线| 特级黄色免费片| 国产第一页屁屁影院| 久久久999国产精品| 精品久久久久久无码中文野结衣 | 校草让我脱了内裤给全班看| 国产在线视频区| 下面一进一出好爽视频| 浪荡女天天不停挨cao日常视频| 国产精品入口麻豆完整版| 久久国产精品成人片免费| 精品久久久久久无码人妻热| 国产精品水嫩水嫩| 久久久精品日本一区二区三区| 精品久久久久久无码中文野结衣 | 黄页网址免费大全观看| 成年人在线视频网站| 亚洲精品无码久久久久秋霞| 精品第一国产综合精品蜜芽| 成年女性特黄午夜视频免费看 | japanesehd日本护士色| 欧美国产中文字幕| 国产v亚洲v天堂无码| 99re视频在线播放| 日本精品3d动漫一区二区| 伊人影院在线视频| 91精品国产人成网站| 女人被男人狂躁免费视频| 亚洲av无码第一区二区三区| 精品熟女碰碰人人a久久| 国产精品无码av片在线观看播| 久久久噜久噜久久gif动图| 特级片在线观看| 国产亚洲精品精品国产亚洲综合|